My annual scan showed no cancer recurrence, but revealed some minor issues related to aging and potential fibroids, requiring ...

After a repeat lymph node biopsy again revealed a grade 3 follicular lymphoma, the patient was considered to have stage IIIA disease and treated at an outside hospital with cyclophosphamide and ...

including follicular lymphoma, treatment may cause shrinkage of the tumor lymph nodes. Sometimes, however, those lymph nodes remain abnormally large while at the same time not containing any ...

001), wherein a pathologic PET activity was observed in normal-sized lymph nodes in 26 of 41 patients ... had evident massive clinical and radiologic lymphoma (stage II in 1 case and stage IV ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the CD19-directed CAR T cell therapy, which is already approved in the EU for certain lymphomas, be authorised to treat ...

The type of Lymphoma with increased risk associated with tattoo exposure seemed to be highest for diffuse large B-cell Lymphoma and Follicular ... of vessels and lymph nodes throughout the body.

Discover how 18F-FDG PET and PET/CT provide critical diagnostic accuracy for detecting high-grade transformations in chronic ...

Medically reviewed by Doru Paul, MD Immunohistochemistry (IHC) is a special test used by pathologists to detect specific ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

Ann LaCasce, MD, MMSc, director of the Dana-Farber/Massachusetts General Brigham Fellowship in Hematology/Oncology, ...